Acute care Test2 Flashcards
Chronic bronchitis
COPD Type
Cough and sputum production, especially during winter
Not due to specific or localized disease
Present on most days for at least 3 months per year for 2 consecutive years
Salmeterol (Serevent)
Rescue inhaler
SABA- short acting
Brochodilator
Adrenergic agonist
Beta-2 specific agonist
LABA- long acting (maintenance)
Time to effect 10-20 min
Duration 12 hours
Side effects- tachycardia, tremors, nervousness, restlessness, weight loss
Disease - air trapping, increased RV, flat diaphragm
Emphysema
SGRQ
St. George’s Respiratory Questionnaire
50Q disease-specific (COPD) instrument designed to measure impact
0-100, lower better
MCID: 4 slightly, 8 moderate, 12 very efficacious
___ position tends to decrease ventilation, which affects ___
Supine
Affects ventilation and perfusion matching (decreased O2 saturation)
Airway- radiograph
Site
Size
Shape
Shadow
Patent, or narrowed indicating stenosis or edema?
Is it central? (It can deviate to R due to aortic arch in adults)
Epinephrine
Bronchodilator
Epi-pen
Nonspecific beta agonist
Used most in emergency (anaphylaxis and sepsis/respiratory failure)
Short time to effect (3-15 min)
Short peak effect time ~20 min
Will affect other tissues with beta and alpha receptors
Children with CHD are at increased risk of …
Developmental disorders, disability or delay
Neurodevelopmental disability affects as many as 50% of infants undergoing interventions for congenital heart lesion.
Children with Down syndrome have impaired tolerance to exercise, altered sympathetic response to exercise and are at increased risk for aneurysm.
MMRC dyspnea scale
Dyspnea with…
Strenuous exercise or walking on slight hill (0 points)
Walking on level ground, must stop d/t sob (1 point)
Must stop d/t sob after 100 yards (2 points)
Dressing/ADL (3 points)
Pathophysiological changes -
Pulmonary problems
Metabolic inefficiency w/ some fiber shift from type 1 -> 2
Reduced FFM (esp quads)
Increased REE (resting energy expenditure) 15-20% above predicted values due to increased work of breathing
Impaired mitochondrial function and decreased density
Multiple suspected causes: disuse atrophy; mitophagy
Indications for oxygen therapy
Hypoxemia
Reduced work of breathing, heart (especially RV)
Typically:
pulse oximetry <88%
OR
SpO2 < 55 mmHg
May also be RX for pt w/ PAH and RV HF
OSA
Obstructive sleep apnea
Intermittent upper airway obstruction (Pharyngeal musculature doesn’t maintain)
Fall in SaO2, increased CO2 levels (hypercapnea)
Sleep disturbance, hypersomnolence
COPD physical exam findings
Chronic cough Sputum production Exertional dyspnea Barrel chest Paradoxical chest wall movements
Crackles, decreased breath sounds, early satiety and difficulty eating, balance and strength deficits, BW changes, cyanosis (severe cases)
Crackles (Rales)
“Popping” open/close of alveoli compressed by fluid
Best heard during inspiration
Sounds like Velcro
Non-cardiogenic : typically 1 lung field; resolves with cough or deep breath
Cardiogenic: (Pulmonary edema from HF) : bilateral lung fields, doesn’t resolve with coughing or deep breath; Resolves with Sidelying
Fick’s principle: oxygen consumption is the product of …
CO and arteriovenous difference
Patent ductus arteriosum results in Cyanotic or Acyanotic deficits
Acyanotic
Muscles of inspiration work against what forces
Elastic recoil of chest wall
Airway resistance
Bi-directional Glenn shunt procedure
Usually performed 4-6 mo old
Creates direct connection between pulmonary artery and superior vena cava
Directly returns venous blood to lungs from UE
R ventricle still pumps mixed blood but procedure reduces its work
Diffusion capacity (DLCO) Dependent on
- Volume inspired
- Pulmonary blood flow
- AC surface area
- Hemoglobin
- Thickness of AC membrane
Generally reduced with emphysema and restriction, normal in asthmatics
PH s/s
Pulmonary HTN progressive dyspnea, particularly with exertion and later at rest Dull retrosternal chest pain Fatigue, lightheaded, fatigue, malaise Exertional syncope Reduced DLC, normal spirometry Non-productive cough Narrow splitting of S2 with loud accentuated pulmonary component (P2) May progress to R side heart failure
Pickwickian syndrome
Obesity- hypoventilation syndrome
Early s/s: headache, fatigue, hyper-somnolence (as with OSA)
Fat deposits on chest wall decrease wall excursion/mobility.
Combines obesity and hypercapnea (high CO2)
Can eventually lead to pulmonary HTN and R ventricular failure
Diphenhydramine
Benedrly
Antihistamine
H1 receptor subtype of histamine involved with respiratory system and hypersensitivity (nasal congestion, sinusitis, rhinitis, mucosal irritation)
Side effects - sedation, fatigue, dizziness, incoordination
COPD: muscle pathophysiological changes
Metabolic inefficiency
Fiber type shift in some skeletal muscles from Type 1 to Type 2
Reduced fat free mass (esp in quads)
Increased resting energy expenditure (REE) 15-20% above predicted values due to increased work of breathing
Impaired mitochondrial function and decreased density
COPD prognosis
Assessment of 4 year survival 4 domains: Severity on FEV1 Distance 6MWT Score on MMRC dyspnea scale BMI (<21 is 1 point- weight loss bad sign)
0-2 80%
3-4 67%
5-6 57%
7-10 18%